•  
  •  
  •  
  •  

2025-08-08 21:53:05

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group

Keywords Selected:  TechnicalWrap

Market Commentary

  • Technical Wrap - Dec 21, 2023 - HDFC Securities
  • Technical Wrap - Dec 8, 2023 - HDFC Securities
  • Technical Wrap - Dec 7, 2023 - HDFC Securities
  • Technical Wrap - Dec 6, 2023 - HDFC Securities
  • Technical Wrap - Dec 5, 2023 - HDFC Securities
  • Technical Wrap - Nov 30, 2023 - HDFC Securities
  • Technical Wrap - Nov 28, 2023 - HDFC Securities
  • Technical Wrap - Nov 24, 2023 - HDFC Securities
  • Technical Wrap - Nov 22, 2023 - HDFC Securities
  • Technical Wrap - Nov 21, 2023 - HDFC Securities
  • Technical Wrap - Nov 20, 2023 - HDFC Securities
  • Technical Wrap - October 3, 2023 - HDFC Securities
  • Technical Wrap - Sep 27, 2023 - HDFC Securities
  • Technical Wrap - Sep 25, 2023 - HDFC Securities
  • Technical Wrap - Sep 22, 2023 - HDFC Securities
  • Technical Wrap - Sep 21, 2023 - HDFC Securities
  • Technical Wrap - Sep 20, 2023 - HDFC Securities
  • Technical Wrap - Sep 15, 2023 - HDFC Securities
  • Technical Wrap - Sep 14, 2023 - HDFC Securities
  • Technical Wrap - Sep 13, 2023 - HDFC Securities
  • Technical Wrap - Sep 12, 2023 - HDFC Securities
  • Technical Wrap - Sep 11, 2023 - HDFC Securities
  • Technical Wrap - Sep 1, 2023 - HDFC Securities
  • Technical Wrap - Aug 30, 2023 - HDFC Securities

Stock Report

  • Technical Wrap - Sep 30, 2022 - HDFC Securities
  • Technical Wrap - Sep 20, 2022 - HDFC Securities

Latest Post

  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024